# Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer

> **NCT00946673** · PHASE1 · COMPLETED · sponsor: **Stanford University** · enrollment: 17 (actual)

## Conditions studied

- Brain Cancer
- Neoplasm Metastasis
- Lung Cancer
- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** Vorinostat
- **PROCEDURE:** Radiation Therapy

## Key facts

- **NCT ID:** NCT00946673
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2014-07
- **Final completion:** 2015-07
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2017-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00946673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00946673, "Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00946673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*